Selective disruption of the blood-brain barrier by photochemical internalization

Henry Hirschberg, Michelle J. Zhang, Michael H. Gach, Francisco A Uzal, David Chighvinadze, Steen J. Madsen

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Introduction: Failure to eradicate infiltrating glioma cells using conventional treatment regimens results in tumor recurrence and is responsible for the dismal prognosis of patients with glioblastoma multiforme (GBM). This is due to the fact that these migratory cells are protected by the blood-brain barrier (BBB) which prevents the delivery of most anti-cancer agents. We have evaluated the ability of photochemical internalization (PCI) to selectively disrupt the BBB in rats. This will permit access of anti-cancer drugs to effectively target the infiltrating tumor cells, and potentially improve the treatment effectiveness for malignant gliomas. Materials and Methods: PCI treatment, coupling a macromolecule therapy of Clostridium perfringens (Cl p) epsilon prototoxin with AlPcS 2a-PDT, was performed on non-tumor bearing inbred Fisher rats. T1-weighted post-contrast magnetic resonance imaging (MRI) scans were used to evaluate the extent of BBB disruption which can be inferred from the volume contrast enhancement. Results: The synergistic effect of PCI to disrupt the BBB was observed at a fluence level of 1 J with an intraperitoneal injection of Cl p prototoxin. At the fluence level of 2.5J, the extent of BBB opening induced by PCI was similar to the result of PDT suggesting no synergistic effect evoked under these conditions. Conclusion: PCI was found to be highly effective and efficient for inducing selective and localized disruption of the BBB. The extent of BBB opening peaked on day 3 and the BBB was completed restored by day 18 post treatment.

Original languageEnglish (US)
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume7161
DOIs
StatePublished - 2009
EventPhotonic Therapeutics and Diagnostics V - San Jose, CA, United States
Duration: Jan 24 2009Jan 26 2009

Other

OtherPhotonic Therapeutics and Diagnostics V
CountryUnited States
CitySan Jose, CA
Period1/24/091/26/09

Fingerprint

blood-brain barrier
Blood
Clostridium
rats
Rats
Tumors
Tumor
Cancer
Cell
fluence
Bearings (structural)
tumors
cancer
Contrast Enhancement
prognosis
Brain
Blood-Brain Barrier
Prognosis
Magnetic Resonance Imaging
Magnetic resonance

ASJC Scopus subject areas

  • Applied Mathematics
  • Computer Science Applications
  • Electrical and Electronic Engineering
  • Electronic, Optical and Magnetic Materials
  • Condensed Matter Physics

Cite this

Hirschberg, H., Zhang, M. J., Gach, M. H., Uzal, F. A., Chighvinadze, D., & Madsen, S. J. (2009). Selective disruption of the blood-brain barrier by photochemical internalization. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 7161). [716136] https://doi.org/10.1117/12.810552

Selective disruption of the blood-brain barrier by photochemical internalization. / Hirschberg, Henry; Zhang, Michelle J.; Gach, Michael H.; Uzal, Francisco A; Chighvinadze, David; Madsen, Steen J.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7161 2009. 716136.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hirschberg, H, Zhang, MJ, Gach, MH, Uzal, FA, Chighvinadze, D & Madsen, SJ 2009, Selective disruption of the blood-brain barrier by photochemical internalization. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 7161, 716136, Photonic Therapeutics and Diagnostics V, San Jose, CA, United States, 1/24/09. https://doi.org/10.1117/12.810552
Hirschberg H, Zhang MJ, Gach MH, Uzal FA, Chighvinadze D, Madsen SJ. Selective disruption of the blood-brain barrier by photochemical internalization. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7161. 2009. 716136 https://doi.org/10.1117/12.810552
Hirschberg, Henry ; Zhang, Michelle J. ; Gach, Michael H. ; Uzal, Francisco A ; Chighvinadze, David ; Madsen, Steen J. / Selective disruption of the blood-brain barrier by photochemical internalization. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7161 2009.
@inproceedings{198c929ccf554babae96f6d6e1a0a6a2,
title = "Selective disruption of the blood-brain barrier by photochemical internalization",
abstract = "Introduction: Failure to eradicate infiltrating glioma cells using conventional treatment regimens results in tumor recurrence and is responsible for the dismal prognosis of patients with glioblastoma multiforme (GBM). This is due to the fact that these migratory cells are protected by the blood-brain barrier (BBB) which prevents the delivery of most anti-cancer agents. We have evaluated the ability of photochemical internalization (PCI) to selectively disrupt the BBB in rats. This will permit access of anti-cancer drugs to effectively target the infiltrating tumor cells, and potentially improve the treatment effectiveness for malignant gliomas. Materials and Methods: PCI treatment, coupling a macromolecule therapy of Clostridium perfringens (Cl p) epsilon prototoxin with AlPcS 2a-PDT, was performed on non-tumor bearing inbred Fisher rats. T1-weighted post-contrast magnetic resonance imaging (MRI) scans were used to evaluate the extent of BBB disruption which can be inferred from the volume contrast enhancement. Results: The synergistic effect of PCI to disrupt the BBB was observed at a fluence level of 1 J with an intraperitoneal injection of Cl p prototoxin. At the fluence level of 2.5J, the extent of BBB opening induced by PCI was similar to the result of PDT suggesting no synergistic effect evoked under these conditions. Conclusion: PCI was found to be highly effective and efficient for inducing selective and localized disruption of the BBB. The extent of BBB opening peaked on day 3 and the BBB was completed restored by day 18 post treatment.",
author = "Henry Hirschberg and Zhang, {Michelle J.} and Gach, {Michael H.} and Uzal, {Francisco A} and David Chighvinadze and Madsen, {Steen J.}",
year = "2009",
doi = "10.1117/12.810552",
language = "English (US)",
volume = "7161",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

}

TY - GEN

T1 - Selective disruption of the blood-brain barrier by photochemical internalization

AU - Hirschberg, Henry

AU - Zhang, Michelle J.

AU - Gach, Michael H.

AU - Uzal, Francisco A

AU - Chighvinadze, David

AU - Madsen, Steen J.

PY - 2009

Y1 - 2009

N2 - Introduction: Failure to eradicate infiltrating glioma cells using conventional treatment regimens results in tumor recurrence and is responsible for the dismal prognosis of patients with glioblastoma multiforme (GBM). This is due to the fact that these migratory cells are protected by the blood-brain barrier (BBB) which prevents the delivery of most anti-cancer agents. We have evaluated the ability of photochemical internalization (PCI) to selectively disrupt the BBB in rats. This will permit access of anti-cancer drugs to effectively target the infiltrating tumor cells, and potentially improve the treatment effectiveness for malignant gliomas. Materials and Methods: PCI treatment, coupling a macromolecule therapy of Clostridium perfringens (Cl p) epsilon prototoxin with AlPcS 2a-PDT, was performed on non-tumor bearing inbred Fisher rats. T1-weighted post-contrast magnetic resonance imaging (MRI) scans were used to evaluate the extent of BBB disruption which can be inferred from the volume contrast enhancement. Results: The synergistic effect of PCI to disrupt the BBB was observed at a fluence level of 1 J with an intraperitoneal injection of Cl p prototoxin. At the fluence level of 2.5J, the extent of BBB opening induced by PCI was similar to the result of PDT suggesting no synergistic effect evoked under these conditions. Conclusion: PCI was found to be highly effective and efficient for inducing selective and localized disruption of the BBB. The extent of BBB opening peaked on day 3 and the BBB was completed restored by day 18 post treatment.

AB - Introduction: Failure to eradicate infiltrating glioma cells using conventional treatment regimens results in tumor recurrence and is responsible for the dismal prognosis of patients with glioblastoma multiforme (GBM). This is due to the fact that these migratory cells are protected by the blood-brain barrier (BBB) which prevents the delivery of most anti-cancer agents. We have evaluated the ability of photochemical internalization (PCI) to selectively disrupt the BBB in rats. This will permit access of anti-cancer drugs to effectively target the infiltrating tumor cells, and potentially improve the treatment effectiveness for malignant gliomas. Materials and Methods: PCI treatment, coupling a macromolecule therapy of Clostridium perfringens (Cl p) epsilon prototoxin with AlPcS 2a-PDT, was performed on non-tumor bearing inbred Fisher rats. T1-weighted post-contrast magnetic resonance imaging (MRI) scans were used to evaluate the extent of BBB disruption which can be inferred from the volume contrast enhancement. Results: The synergistic effect of PCI to disrupt the BBB was observed at a fluence level of 1 J with an intraperitoneal injection of Cl p prototoxin. At the fluence level of 2.5J, the extent of BBB opening induced by PCI was similar to the result of PDT suggesting no synergistic effect evoked under these conditions. Conclusion: PCI was found to be highly effective and efficient for inducing selective and localized disruption of the BBB. The extent of BBB opening peaked on day 3 and the BBB was completed restored by day 18 post treatment.

UR - http://www.scopus.com/inward/record.url?scp=66249135656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66249135656&partnerID=8YFLogxK

U2 - 10.1117/12.810552

DO - 10.1117/12.810552

M3 - Conference contribution

AN - SCOPUS:66249135656

VL - 7161

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

ER -